Clinical Trials Sponsored by Andersen Foundation

Total 18894 results

M.D. Anderson Cancer Center

Completed

Effect of Physician Attire on Patients' Preference of Physician

Malignant Neoplasms of Independent (Primary) Multiple Sites

United States
M.D. Anderson Cancer Center

Completed

Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging

Cancer of Lymph Node

United States
M.D. Anderson Cancer Center

Completed

Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

Ductal Carcinoma In Situ

United States
M.D. Anderson Cancer Center

Completed

Melanoma Risk-Reduction Among Patients and Family Members

Melanoma

United States
M.D. Anderson Cancer Center

Completed

Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Primary Breast Cancer Occurring Concomitant With Pregnancy

Breast Cancer | Pregnancy

United States
M.D. Anderson Cancer Center

Completed

Study of Vemurafenib, Carboplatin, and Paclitaxel

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Simultaneous Integrated Boost (SIB) in Esophageal Cancer

Esophageal Cancer

United States
M.D. Anderson Cancer Center

Completed

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Leukemia

United States
M.D. Anderson Cancer Center

Completed

SRS Study in Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma | Brain Cancer

United States
M.D. Anderson Cancer Center

Completed

A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States
M.D. Anderson Cancer Center

Completed

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

Leukemia

United States
M.D. Anderson Cancer Center

Completed

REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)

Heart Failure | Cancer Treatment Induced Left Ventricular Dysfunction

United States
M.D. Anderson Cancer Center

Terminated

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Ewing's Sarcoma

United States
M.D. Anderson Cancer Center

Unknown

Understanding Patient's Knowledge and Use of Acetaminophen

Liver Failure

United States
M.D. Anderson Cancer Center

Completed

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

Lymphoma | Advanced Cancers

United States
M.D. Anderson Cancer Center

Withdrawn

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Lymphoma | Leukemia | Blood And Marrow Transplantation
M.D. Anderson Cancer Center

Unknown

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
M.D. Anderson Cancer Center

Terminated

Metformin in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

Lymphoma

United States
M.D. Anderson Cancer Center

Terminated

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Lymphoma

United States
M.D. Anderson Cancer Center

Completed

Melanoma Vaccine With Peptides and Leuprolide

Melanoma

United States
M.D. Anderson Cancer Center

Unknown

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

Cancer | Venous Thromboembolism

United States
Anderson Orthopaedic Research Institute

Completed

Study of Total Hip Arthroplasty Using Radlink Surgical Positioning Software

Total Hip Replacement
M.D. Anderson Cancer Center

Completed

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center

Unknown

Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors

Breast Cancer | Colorectal Cancer | Prostate Cancer

United States
M.D. Anderson Cancer Center

Unknown

Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection

Lung Cancer

United States
M.D. Anderson Cancer Center

Unknown

Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics

Pediatric Cancer

United States
M.D. Anderson Cancer Center

Terminated

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

Pancreatic Cancer

United States
M.D. Anderson Cancer Center

Completed

Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Doxil, Bevacizumab and Temsirolimus Trial

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

Cancer | Complications | Surgical Procedure, Unspecified | Other Reconstructive Surgery | Failure of Muscle Graft

United States
M.D. Anderson Cancer Center

Completed

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery

Laparoscopy

United States
M.D. Anderson Cancer Center

Terminated

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Prostate Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease

Lymphoma | Hodgkin's Disease
M.D. Anderson Cancer Center

Terminated

Use of Nesiritide in the Management of Acute Diastolic Heart Failure

Heart Failure | Cardiovascular Disease | Heart Disease | Congestive Heart Failure | Acute Heart Failure | Diastolic Heart Failure
M.D. Anderson Cancer Center

Completed

Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Study of Vioxx and Radiation Therapy for Brainstem Glioma

Glioma | Brain Neoplasms

United States
M.D. Anderson Cancer Center

Terminated

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

Pancreatic Neoplasms

United States
M.D. Anderson Cancer Center

Completed

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Metastases, Neoplasm | Neuroendocrine Tumors

United States
M.D. Anderson Cancer Center

Completed

Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

Myelogenous Leukemia, Chronic

United States
M.D. Anderson Cancer Center

Completed

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

United States
M.D. Anderson Cancer Center

Completed

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Hematologic Neoplasms | Lymphoma, T-Cell | Mycosis Fungoides

United States
M.D. Anderson Cancer Center

Completed

3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Leukemia | AML

United States
M.D. Anderson Cancer Center

Withdrawn

Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

Malignant Neoplasms of Mesothelial and Soft Tissue | Rhabdomyosarcoma, Pelvic | Rhabdomyosarcoma, Abdominal
M.D. Anderson Cancer Center

Completed

Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma

Colorectal Cancer

United States

Clinical Trials Sponsored by Andersen Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations